Company’s innovation program is spearheaded by over 50 researchers working on differentiated medicines for the future. Company’s key strength is embedded in its cutting-edge research and development capabilities and It has successfully filled 25 plus patent applications and is awarded seven patents.
Innovations at Lincoln have resulted in filing of 25 patents for New Drug Delivery Technologies and New Drug Discovery programs as well as innovative processes of API & formulations for various geographies and 7 patents have been granted so far.